Akero Therapeutics | Efruxifermin (EFX) for NASH | Contact

Akero Therapeutics Announces Phase 2b SYMMETRY Data.

We thrive on collaboration! Please get in touch if you are interested in learning more.

Akero Therapeutics

601 Gateway Boulevard,
Suite 350
South San Francisco, CA 94080
(650) 487-6488

601 Gateway Boulevard Suite 350 South San Francisco, CA 94080

Request Information

Name(Required)

First Last

Phone(Required)

Email(Required)

Field of Inquiry(Required)

Message(Required)

Our focus is on developing therapies to address serious metabolic diseases.

View Therapeutic Areas

PSB_Image_4